---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-120352"
form_type: "8-K"
ticker: "ADGM"
cik: "0002006986"
company_name: "Adagio Medical Holdings, Inc."
filed_at: "2025-12-11T23:59:59+00:00"
generated_at: "2026-05-16T13:33:22.765472+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Adagio Medical expands board to seven, appoints former Medtronic EVP Sean Salmon

## Summary
- Board increased from six to seven directors; Salmon appointed Class II director, term expiring at 2026 annual meeting.
- Salmon served as Medtronic EVP and President of Cardiovascular Portfolio from Jan 2021 to Sep 2025.
- Appointed to Audit and Compensation Committees; will receive standard non-employee director compensation.
- Company entered into standard indemnification agreement with Salmon.
- No arrangements or material transactions with any other person in connection with appointment.

## SEC filing metadata
- accession: 0001104659-25-120352
- form_type: 8-K
- ticker: ADGM
- cik: 0002006986
- company_name: Adagio Medical Holdings, Inc.
- filed_at: 2025-12-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006986/000110465925120352/0001104659-25-120352-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006986/000110465925120352/tm2533309d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-120352
- JSON: https://secwatch.observer/filing/0001104659-25-120352.json
- Plain text: https://secwatch.observer/filing/0001104659-25-120352.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.